Danielsson K, Olah J, Zohori-Zangeneh R, Nylander E, Ebrahimi M. Increased expression of p16 in both oral and genital lichen planus. Med Oral Patol Oral Cir Bucal. 2018 Jul 1;23 (4):e449-53.
doi:10.4317/medoral.22432
http://dx.doi.org/doi:10.4317/medoral.22432
________________________________________________________________________________
|
1.
Ebrahimi M1, Wahlin YB, Coates PJ, Wiik A, Roos G, Nylander K. Detection of
antibodies against p63 and p73 isoforms in sera from patients diagnosed with
oral lichen planus. J Oral Pathol Med. 2007;36:93-8. |
|
|
|
|
|
2.
Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L. Increased levels
of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol.
2012;26:1415-9. |
|
|
|
|
|
3.
Danielsson K, Boldrup L, Rentoft M, Coates PJ, Ebrahimi M, Nylander E, et al.
Autoantibodies and decreased expression of the transcription factor ELF-3
together with increased chemokine pathways support an autoimmune phenotype
and altered differentiation in lichen planus located in oral mucosa. J Eur Acad Dermatol Venereol. 2013;
27:1410-6. |
|
|
|
|
|
4.
Montebugnoli L, Venturi M, Gissi DB, Leonardi E, Farnedi A, Foschini MP.
Immunohistochemical expression of p16(INK4A) protein in oral lichen planus.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:222-7. |
|
|
|
|
|
5.
Ebrahimi M, Lundqvist L, Wahlin YB, Nylander E. Mucosal lichen planus, a
systemic disease requiring multidisciplinary care: a cross-sectional clinical
review from a multidisciplinary perspective. J Low Genit Tract Dis.
2012;16:377-80. |
|
|
|
|
|
6.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and
classification of potentially malignant disorders of the oral mucosa. J Oral
Pathol Med. 2007:36:575-80. |
|
|
|
|
|
7.
van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der
Waal I. A review of the recent literature regarding malignant transformation
of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:307-10. |
|
|
|
|
|
8.
Mattsson U, Jontell M, Holmstrup P. Oral lichen planus and malignant
transformation: is a recall of patients justified? Crit Rev Oral Biol Med. 2002;13:390-6. |
|
|
|
|
|
9.
Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control
causing specific inhibition of cyclin D/CDK4. Nature. 1993;366:704-7. |
|
|
|
|
|
10.
Sgaramella N, Coates PJ, Strindlund K, Loljung L, Colella G, Laurell G, et
al., Expression of p16 in squamous cell carcinoma of the mobile tongue is
independent of HPV infection despite presence of the HPV-receptor syndecan-1.
Br J Cancer. 2015;113:321-6. |
|
|
|
|
|
11.
Goel S, Khurana N, Marwah A, Gupta S. Expression of cdk4 and p16 in Oral
Lichen Planus. J Oral Maxillofac Res. 2015;6:e4. |
|
|
|
|
|
12.
Salehinejad J, Sharifi N, Amirchaghmaghi M, Ghazi N, Shakeri MT, Ghazi A.
Immunohistochemical expression of p16 protein in oral squamous cell carcinoma
and lichen planus. Ann
Diagn Pathol. 2014;18:210-3. |
|
|
|
|
|
13.
Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Overexpression of cdk4
and p16 in oral lichen planus supports the concept of premalignancy. J Oral
Pathol Med. 2011;40:294-9. |
|
|
|
|
|
14.
Cunningham LL Jr, Pagano GM, Li M, Tandon R, Holm SW, White DK, et al.
Overexpression of p16INK4 is a reliable marker of human
papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 2006;102:77-81. |
|
|
|
|
|
15.
Bradley KT, Budnick SD, Logani S. Immunohistochemical detection of p16INK4a
in dysplastic lesions of the oral cavity. Mod Pathol. 2006;19:1310-6. |
|
|
|
|
|
16.
Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for
immunohistochemical semiquantitation: validation for oestrogen receptor in
breast carcinomas. J Clin Pathol. 1995;48:876-8. |
|
|
|
|
|
17.
Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk
of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol.
2018;125:612-627. |
|
|
|
|
|
18.
Mannweiler S, Sygulla S, Winter E, Regauer S. Two major pathways of penile
carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative
cancers associated with dermatoses express p53, but lack p16ink4a
overexpression. J Am Acad Dermatol. 2013;69:73-81. |
|
|
|
|
|
19.
Regauer S, Reich O, Eberz B. Vulvar cancers in women with vulvar lichen
planus: a clinicopathological study. J Am Acad Dermatol. 2014;71:698-707. |
|
|
|
|
|
20.
Schmitz ML, Kracht M. Cyclin-Dependent Kinases as Coregulators of
Inflammatory Gene Expression. Trends Pharmacol Sci. 201637:101-113. |
|
|
|
|
|
21.
Loizou C, Laurell G, Lindquist D, Öfverman C, Stefansson K, Nylander K, et
al. Incidence of tonsillar cancer in northern Sweden: Impact of human
papilloma virus. Oncol
Lett. 2015;10:3565-3572. |
|
|
|
|
|
22.
Montebugnoli L, Gissi DB, Scapoli L, Palmieri A, Morandi L, Manelli I,
Foschini MP. p16(INK4) expression is not associated with human papillomavirus
in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol.
2014;118:694-702. |
|
|
|
|
|
23.
Lu R, Zhang J, Sun W, Du G, Zhou G. Inflammation-related cytokines in
orallichen planus: an overview. J Oral Pathol Med. 2015;44:1-14. |
|
|
|
|
|
24.
Sklavounou-Andrikopoulou A, Chrysomali E, Iakovou M, Garinis GA, Karameris A.
Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1
and Bcl-2 in oral lichen planus. J Oral Pathol Med. 2004;33:386-90. |
|
|
|
|
|
25.
Khan A, Farah CS, Savage NW, Walsh LJ, Harbrow DJ, Sugerman PB. Th1 cytokines
in oral lichen planus. J Oral Pathol Med. 2003;32:77-83. |
|
|
|
|
|
26.
Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment.
J Immunol Res. 2014;2014:149185. |
|
|
|
|
|
27.
Lebrec H, Ponce R, Preston BD, Iles J, Born TL, Hooper M. Tumor necrosis
factor, tumor necrosis factor inhibition, and cancer risk. Curr Med Res Opin. 2015;31:557-74. |
|
|
|
|
|
28.
Harvat BL, Jetten AM. Decreased growth inhibitory responses of squamous
carcinoma cells to interferon-gamma involve failure to recruit cki proteins
into cdk2 complexes. J Invest Dermatol. 2001;117:1274-81. |
|
|
|
|
|
29.
Satgunaseelan L, Virk SA, Lum T, Gao K, Clark JR, Gupta R. p16 expression
independent of human papillomavirus is associated with lower stage and longer
disease-free survival in oral cavity squamous cell carcinoma. Pathology. 2016;48:441-8. |
|
|
|
|
|
30. Shah NG,
Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell
carcinoma: a multivariate analysis. Head Neck. 2009;31:1544-56. |
|
|
|
|
|
31.
Natarajan E, Omobono JD 2nd, Guo Z, Hopkinson S, Lazar AJ, Brenn T, et al. A keratinocyte hypermotility/growth-arrest response
involvinglaminin 5 and p16INK4A activated in wound healing and senescence. Am
J Pathol. 2006;168:1821-37. |
|